Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Eton Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +4 vs. Q2 2024
- Shares held
- 10.0M
- +1.56M (+18.5%) vs. Q2 2024
- Total value
- $60.0M
- +$32.2M (+116.1%) vs. Q2 2024
- New holders
- 13
- 11 more added
- Sold out
- 9
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 201 | $1.21K | 0.00% | +18+9.8% | Added |
| Advisor Group Holdings, Inc. | 300 | $1.80K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 275 | $2.00K | 0.00% | −472−63.2% | Reduced |
| BNP Paribas Arbitrage, SA | 350 | $2.10K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 472 | $2.83K | 0.00% | +280+145.8% | Added |
| Group One Trading, L.P. | 722 | $4.33K | 0.00% | +722 | New |
| JPMorgan Chase & Co | 723 | $4.34K | 0.00% | +723 | New |
| Plante Moran Financial Advisors, LLC | 1,000 | $6.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 1,183 | $7.10K | 0.00% | +1,183 | New |
| Cubist Systematic Strategies, LLC | 8,269 | $49.6K | 0.00% | +8,269 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 8,927 | $53.6K | 0.01% | +8,927 | New |
| Raymond James & Associates | 10,250 | $61.5K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 11,304 | $67.8K | 0.00% | −435−3.7% | Reduced |
| Quantum Private Wealth, LLC | 11,500 | $69.0K | 0.02% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 12,170 | $73.0K | 0.01% | +12,170 | New |
| Charles Schwab Investment Management Inc | 13,239 | $79.4K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 15,006 | $90.0K | 0.00% | +15,006 | New |
| Chicago Trust Co NA | 16,700 | $100.2K | 0.02% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 17,200 | $103.2K | 0.00% | −33,717−66.2% | Reduced |
| UBS Group AG | 19,017 | $114.1K | 0.00% | +7,999+72.6% | Added |
| Marshall Wace, LLP | 20,637 | $123.8K | 0.00% | +20,637 | New |
| Citigroup Inc | 26,495 | $159.0K | 0.00% | +26,495 | New |
| Essex Investment Management Co LLC | 27,252 | $163.5K | 0.03% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 32,342 | $194.1K | 0.00% | +32,338+808,450.0% | Added |
| Blair William & Co | 34,500 | $207.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 64,130 | $384.8K | 0.00% | +4,281+7.2% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 65,014 | $390.1K | 0.00% | +30,167+86.6% | Added |
| Bank of New York Mellon Corp | 74,491 | $446.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,403 | $488.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 83,400 | $500.4K | 0.00% | −23,100−21.7% | Reduced |
| Acadian Asset Management LLC | 105,954 | $634.0K | 0.00% | −14,620−12.1% | Reduced |
| Thompson Siegel & Walmsley LLC | 115,030 | $690.0K | 0.01% | −12,694−9.9% | Reduced |
| Susquehanna International Group, LLP | 119,347 | $716.1K | 0.00% | −14,941−11.1% | Reduced |
| EAM Investors, LLC | 128,276 | $769.7K | 0.12% | +128,276 | New |
| Aristides Capital LLC | 200,000 | $1.20M | 0.50% | 00.0% | Unchanged |
| Wasatch Advisors Inc | 238,565 | $1.43M | 0.01% | +238,565 | New |
| Bridgeway Capital Management, LLC | 253,362 | $1.52M | 0.03% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 260,226 | $1.56M | 0.20% | +7,029+2.8% | Added |
| Geode Capital Management, LLC | 272,696 | $1.64M | 0.00% | +32,365+13.5% | Added |
| BlackRock, Inc. | 284,855 | $1.71M | 0.00% | +284,855 | New |
| Paradigm Capital Management Inc | 300,000 | $1.80M | 0.08% | 00.0% | Unchanged |
| National Philanthropic Trust | 492,112 | $2.95M | 0.05% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 566,075 | $3.40M | 0.12% | +566,075 | New |
| Acuitas Investments, LLC | 579,960 | $3.48M | 1.55% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 618,675 | $3.71M | 0.79% | +33,275+5.7% | Added |
| Nantahala Capital Management, LLC | 998,733 | $5.99M | 0.50% | +58,000+6.2% | Added |
| Vanguard Group Inc | 1,027,688 | $6.17M | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,780,000 | $16.7M | 2.78% | +385,000+16.1% | Added |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −57,503−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −41,255−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,485−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −10,564−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,638−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |